-
Semaglutide
Semaglutide is a medication approved for the treatment of obesity in adults. It is a glucagon-like peptide-1 receptor agonist (GLP-1 RA), similar to those used for managing type 2 diabetes, but in higher doses specifically formulated for weight management.
-
Tirzepatide
Tirzepatide is a medication that has shown promise for weight loss in clinical trials. It belongs to a class of drugs called dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor agonists (GLP-1 RA). Originally developed for the treatment of type 2 diabetes, it is now being investigated for its potential to aid in weight management.
